Cargando…

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer

OBJECTIVE: There is a need for early detection of colorectal cancer (CRC) at precancerous-stage adenoma. Here, we identified novel faecal bacterial markers for diagnosing adenoma. DESIGN: This study included 1012 subjects (274 CRC, 353 adenoma and 385 controls) from two independent Asian groups. Can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jessie Qiaoyi, Li, Tong, Nakatsu, Geicho, Chen, Ying-Xuan, Yau, Tung On, Chu, Eagle, Wong, Sunny, Szeto, Chun Ho, Ng, Siew C, Chan, Francis K L, Fang, Jing-Yuan, Sung, Joseph J Y, Yu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Gut Microbiota
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306980/ https://www.ncbi.nlm.nih.gov/pubmed/31776231 http://dx.doi.org/10.1136/gutjnl-2019-318532

Ejemplares similares

Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2019)

Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018)

Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis
por: Sugimura, Naoki, et al.
Publicado: (2022)

Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma
por: Chen, Feng, et al.
Publicado: (2022)

Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)
por: Ng, Siew C, et al.
Publicado: (2020)

Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
por: Sbahi, Hani, et al.
Publicado: (2016)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
por: Yeoh, Yun Kit, et al.
Publicado: (2021)

Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells
por: Kang, Xing, et al.
Publicado: (2023)

Gut mucosal virome alterations in ulcerative colitis
por: Zuo, Tao, et al.
Publicado: (2019)

Blue poo: impact of gut transit time on the gut microbiome using a novel marker
por: Asnicar, Francesco, et al.
Publicado: (2021)

Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer
por: Guo, Yang, et al.
Publicado: (2020)

Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect
por: Wang, Xingmin, et al.
Publicado: (2015)

Human and preclinical studies of the host–gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health
por: Brial, François, et al.
Publicado: (2021)

Gut microbiome modulates the effects of a personalised postprandial-targeting (PPT) diet on cardiometabolic markers: a diet intervention in pre-diabetes
por: Ben-Yacov, Orly, et al.
Publicado: (2023)

Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC
por: Awoniyi, Muyiwa, et al.
Publicado: (2023)

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
por: Serino, Matteo, et al.
Publicado: (2011)

Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88
por: Larsson, Erik, et al.
Publicado: (2011)

Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet
por: Manichanh, Chaysavanh, et al.
Publicado: (2014)

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2013)

Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates
por: Vandeputte, Doris, et al.
Publicado: (2016)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia
por: Schuijt, Tim J, et al.
Publicado: (2016)

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
por: Chambers, Edward S, et al.
Publicado: (2015)

Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence
por: Schaubeck, Monika, et al.
Publicado: (2016)

Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
por: Lavelle, A, et al.
Publicado: (2015)

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
por: Sabino, João, et al.
Publicado: (2016)

Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction
por: Catry, Emilie, et al.
Publicado: (2018)

Gut symbiotic microbes imprint intestinal immune cells with the innate receptor SLAMF4 which contributes to gut immune protection against enteric pathogens
por: Cabinian, Allison, et al.
Publicado: (2018)

Changes in the gut microbiota composition and the plasma ghrelin level in patients with Helicobacter pylori-infected patients with eradication therapy
por: Yanagi, Hidetaka, et al.
Publicado: (2017)

Prebiotic inulin-type fructans induce specific changes in the human gut microbiota
por: Vandeputte, Doris, et al.
Publicado: (2017)

Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus
por: Wang, Jinfeng, et al.
Publicado: (2018)

International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
por: Scott, Alasdair J, et al.
Publicado: (2019)

Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice
por: Wu, Wei-Kai, et al.
Publicado: (2019)

Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial
por: Chambers, Edward S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ob53jo7hllrg2hlk59effslc0t